Application of tumor necrosis factor antagonists in hepatic disease treatment
All tumor necrosis factor (TNF) antagonists are associated with hepatotoxicity and thus induce liver injury, commonly manifested as hepatitis B virus and hepatitis C virus reactivation, acute hepatitis, drug-induced liver disease, cholestasis, serum liver enzyme activity elevation, and even acute li...
Main Authors: | CHI Zhaochun, GENG Changxin |
---|---|
Format: | Article |
Language: | zho |
Published: |
Editorial Department of Journal of Clinical Hepatology
2015-07-01
|
Series: | Linchuang Gandanbing Zazhi |
Online Access: | http://www.lcgdbzz.org/qk_content.asp?id=6666 |
Similar Items
-
Demyelinizing Neurological Disease after Treatment with Tumor Necrosis Factor-α Antagonists
by: Claudia Bruè, et al.
Published: (2016-07-01) -
Impact of tumor necrosis factor alpha antagonist treatment on antibody titer of hepatitis B surface antigen
by: Beytullah Yıldırım, et al.
Published: (2020-08-01) -
Differences in pharmacology of tumor necrosis factor (TNF) antagonists
by: S. Bombardieri, et al.
Published: (2011-09-01) -
Nontuberculous Mycobacterium Infection and Tumor Necrosis Factor-α Antagonists
by: Reinout M. Swart, et al.
Published: (2009-10-01) -
No impact of tumor necrosis-factor antagonists on the joint manifestations of sarcoidosis
by: Banse C, et al.
Published: (2013-07-01)